您当前的位置：
首页 >
文章列表页 >
Clinical observation of intravitreal injection of ranibizumab in the treatment of macular edema with different OCT subtypes of retinal vein obstruction
更新时间：2025-11-10

    • Clinical observation of intravitreal injection of ranibizumab in the treatment of macular edema with different OCT subtypes of retinal vein obstruction

    • “In the field of ophthalmic treatment, a research team from Tianjin Eye Hospital analyzed the efficacy and influencing factors of ranibizumab in treating macular edema secondary to retinal vein occlusion. They found that there were differences in the efficacy of different OCT subtypes, and CRVO and ischemic type were common risk factors for poor prognosis.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 21, Pages: 2699-2704(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.21.14    

      CLC： R988.1;R969.4

    • Received：07 July 2025，

      Revised：2025-09-26，

      Accepted：28 September 2025，

      Published：15 November 2025

    移动端阅览

  • CHEN Ying,XUE Chao,CHEN Jiaxing.Clinical observation of intravitreal injection of ranibizumab in the treatment of macular edema with different OCT subtypes of retinal vein obstruction[J].ZHONGGUO YAOFANG,2025,36(21):2699-2704. DOI： 10.6039/j.issn.1001-0408.2025.21.14.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Analysis of clinical characteristics and influential factors of drug-induced liver injury in children caused by intravenous azithromycin
Clinical efficacy and influencing factors of ceftazidime and avibactam monotherapy versus combination therapy in the treatment of CRGNB infection
Study on the influential factors for clinical efficacy of polymyxin B combined with other antibiotics in the treatment of carbapenem-resistant Acinetobacter baumannii pulmonary infection
Investigation on the current status of pharmaceutical care in medical institutions in China
Analysis of the standardization and influential factors in the prevention and treatment of glucocorticoid-induced osteoporosis with drugs

Related Author

LI Wanhui
LYU Xiaoqian
SU Dan
HUO Baofeng
CHEN Hejun
YAN Ping
LIU Changwei
WANG Xiaohua

Related Institution

Dept. of Pharmacy， Hengshui People’s Hospital
Dept. of Pediatric Internal Medicine， Hengshui People’s Hospital
Dept. of Infectious Diseases， the First Affiliated Hospital of Anhui Medical University
Grade Ⅲ Pharmaceutical Chemistry Laboratory of TCM， National Administration of Traditional Chinese Medicine
Dept. of Pharmacy， the First Affiliated Hospital of Anhui Medical University
0